Changes in bone formation regulator biomarkers in early axial spondyloarthritis.

Further Publications Rheumatology

Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine

Ann Rheum Dis

Renson T, Carron P, De Craemer AS, Deroo L, de Hooge M, Krabbe S, Jans L, Chen M, Østergaard M, Van den Bosch FE, Elewaut D

doi: 10.1136/annrheumdis-2020-218480

EULAR ^® 2020

Axial Spondyloarthritis

Rheumatoid Arthritis

Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.

Arthritis Res Ther.

Boyapati A, Msihid J, Fiore S, van Adelsberg J, Graham NM, Hamilton JD

OsteoporosisRheumatoid Arthritis

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study

Calcif Tissue Int.

Hauser B, Zhao S, Visconti MR, Riches PL, Fraser WD, Piec I, Goodson NJ, Ralston SH

doi: 10.1007/s00223-017-0291-2.

Psoriatic Arthritis

Editorial: Sacroiliac Joint Magnetic Resonance Imaging in the Diagnosis of Axial Spondyloarthritis: “A Tiny Bit of White on Two Consecutive Slices” May Be Objective, but Not Specific

Pfeffer MA, Claggett B, Diaz R, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-2257 Full Text | Web of Science | Medline

Spinal Disorders

Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort

Rheumatology (Oxford).

Hirano F, van der Heijde D, van Gaalen FA, Landewé RBM, Gaujoux-Viala C, Ramiro S

doi: 10.1093/rheumatology/keaa353.

Spinal Disorders

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Ann Rheum Dis.

Landewé RB, van der Heijde D, Dougados M, Baraliakos X, Van den Bosch FE, Gaffney K, Bauer L, Hoepken B, Davies OR, de Peyrecave N, Thomas K, Gensler L

doi: 10.1136/annrheumdis-2019-216839.

Spinal Disorders

Diagnostic value of anti-CD74 antibodies in early and late axial spondyloarthritis and its relationship to disease activity

Rheumatology (Oxford).

Abdelaziz MM, Gamal RM, Ismail NM, Lafy RA, Hetta HF

doi: 10.1093/rheumatology/keaa292.

Further Publications Rheumatology

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort

Rheumatology (Oxford)

Nikiphorou E, Boonen A, Fautrel B, Richette P, Landewé R, van der Heijde D, Ramiro S

doi: 10.1093/rheumatology/keab607

Related content

Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine

Axial Spondyloarthritis

Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study

Editorial: Sacroiliac Joint Magnetic Resonance Imaging in the Diagnosis of Axial Spondyloarthritis: “A Tiny Bit of White on Two Consecutive Slices” May Be Objective, but Not Specific

Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Diagnostic value of anti-CD74 antibodies in early and late axial spondyloarthritis and its relationship to disease activity

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort